share_log

Keros Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alkeon Capital Management, LLC(5.0%),Panayotis D. Sparaggis(5.0%)

Keros Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Alkeon Capital Management, LLC(5.0%),Panayotis D. Sparaggis(5.0%)

美股SEC公告 ·  02/13 18:40
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息